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The granulocyte colony-stimulating factor receptor (G-CSF-R) transduces signals important for the
proliferation and maturation of myeloid progenitor cells. To identify functionally important regions in the
cytoplasmic domain of the G-CSF-R, we compared the actions of the wild-type receptor, two mutants, and a
natural splice variant in transfectants of the mouse pro-B cell line BAF3 and two myeloid cell lines, 32D and
L-GM. A region of 55 amino acids adjacent to the transmembrane domain was found to be sufficient for
generating a growth signal. The immediate downstream sequence of 30 amino acids substantially enhanced the
growth signaling in the three cell lines. In contrast, the carboxy-terminal part of 98 amino acids strongly
inhibited growth signaling in the two myeloid cell lines but not in BAF3 cells. Truncation of this region lead to
an inability of the G-CSF-R to transduce maturation signals in L-GM cells. An alternative carboxy tail present
in a splice variant of the G-CSF-R also inhibited growth signaling, notably in both the myeloid cells and BAF3
cells, but appeared not to be involved in maturation.
The formation of blood cells in the bone marrow is
controlled by a regulatory network of hematopoietic growth
factors (5, 23). One of these factors, granulocyte colony-
stimulating factor (G-CSF) secreted by macrophages, fibro-
blasts, and endothelial cells, plays an essential role in the
regulation of granulopoiesis and the maintenance of neutro-
phil levels in the peripheral blood. For instance, G-CSF not
only is able to stimulate the proliferation of neutrophilic
progenitor cells but also induces maturation of these progen-
itor cells towards neutrophilic granulocytes (8, 24, 32).
The murine and human receptors for G-CSF (G-CSF-R)
consist of a single polypeptide with a molecular weight of
130,000 to 150,000 (10, 44). The high-affinity interaction
between G-CSF and its receptor and subsequent activation
of receptor signaling require the formation of homodimeric
or oligomeric receptor complexes (10). The molecular clon-
ing of the cDNAs encoding the murine and human G-CSF-R
revealed that the murine and human G-CSF-R contain 812
and 813 amino acids, respectively, with a single transmem-
brane domain (12, 13, 21). The structure of the G-CSF-R
shows significant homology to that of the interleukin-6 (IL-6)
signal transducer gpl30 (16, 38). Expression of the G-CSF-R
cDNAs in murine hematopoietic cells leads to formation of
high-affinity G-CSF binding sites on the cell surface and
renders these cells responsive to G-CSF (11, 49). At least
four different forms of the human G-CSF-R, resulting from
alternative splicing of G-CSF receptor mRNA, have been
cloned from human placenta and myeloid leukemia (U937)
cells (13, 21).
On the basis of structural similarities, the G-CSF-R has
been classified as a member of the superfamily of cytokine
receptors (1, 6). The homologous structures shared by the
members of the family consist of four conserved cysteine
residues and a WSXWS motif in the extracellular region.
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The cytoplasmic domain of the family is less conserved, but
certain sequence similarities have been reported among the
receptors for IL-3 to IL-7, G-CSF, granulocyte macrophage-
CSF, erythropoietin (EPO), and the ,B chains of IL-2 and
IL-3 (11, 29). Several studies have delineated functionally
important regions in the cytoplasmic domain. For instance, a
membrane-proximal region of the EPO receptor (EPO-R),
IL-6 signal transducer gpl30, and the P chains of IL-2 and
IL-3 is essential for transmitting a growth signal (7, 15, 29,
39). In agreement with these findings, it has been established
that the membrane-proximal region of the G-CSF-R is indis-
pensible for growth signal transduction (11, 48). The cyto-
plasmic tail of the EPO-R has been shown to down-modulate
the mitogenic response to EPO (7, 35). In contrast, the distal
cytoplasmic region of the G-CSF-R has been reported to
enhance growth signaling potential (11).
In this paper, we describe the identification of two cyto-
plasmic regions of the wild-type (WT) G-CSF-R, located
distal to the box 1- and box 2-containing region, one that
positively and one that negatively regulates the mitogenic
response to G-CSF. We provide evidence showing that a
distinct carboxy terminus present in a G-CSF-R splice
variant also inhibits growth signaling. Further, we show that
the negative regulatory region of the WT G-CSF-R but not of
the splice variant is essential for G-CSF-induced neutro-
philic maturation. These findings establish that distinct re-
gions of the cytoplasmic domain of the G-CSF-R have a
determinative role in G-CSF-induced proliferation and mat-
uration of myeloid progenitor cells.
MATERUILS AND METHODS
Cell lines and culture. The murine pro-B cell line BAF3
(34) was kindly provided by G. Plaetinck (Roche Research,
Ghent, Belgium) and maintained in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS) and 10 ng of
murine IL-3 per ml. Murine myeloid cell lines 32D (14) and
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L-GM (22) were provided by J. S. Greenberger (University
of Massachusetts) and T. Honjo (Kyoto University Faculty
of Medicine, Kyoto, Japan). 32D and L-GM cells were
maintained in RPMI 1640 medium supplemented with 10%
FCS and 10% WEHI-3B cell conditioned medium (WEHI-
CM) as a source of murine IL-3.
G-CSF-R expression constructs. For the construction of
pLNCX-WT, the WT human G-CSF-R cDNA (13) (pHQ3,
kindly provided by S. Nagata and R. Fukunaga) was excised
from the pBluescript vector and inserted into the HpaI site
of the retroviral expression vector pLNCX (25). For the
construction of pLNCX-DC, reverse transcriptase-poly-
merase chain reaction (RT-PCR) was performed on total
RNA isolated from normal granulocytes by using forward
primer 5'TGTGATCATCGTGACTCCCTT3' (FW2) and re-
verse primer 5'CAAGATCTAGTIlTACAATACTGAAG3'
(RV2), and an 864-bp PCR fragment was subcloned into the
pBluescript vector. A 248-bp stretch of the fragment was
then cut out with BsrFI and ClaI and, together with the
HindIII-BsrFI fragment obtained from pLNCX-WT, was
inserted into HindIII-ClaI-cleaved pLNCX vector by triple
ligation. Mutant DA was isolated from granulocytes of a
patient with congenital neutropenia by RT-PCR using the
same set of primers. The construction of the full-length DA
mutant is essentially same as that described for the DC
receptor. Mutant Ml was generated by PCR by introducing
a termination codon at amino acid position 686 of the WT
G-CSF-R. The PCR fragment was first ligated to the HincII
site of the pBluescript vector and then excised from the
plasmid by HindIII and XhoI digestion, blunt ended, and
inserted into the HpaI site of pLNCX.
DNA transfection. The pLNCX expression constructs
were linearized by PvuI digestion and transfected into
BAF3, 32D, and L-GM cells by electroporation. Following
gene transfer, cells were cultured in IL-3-containing medium
for 48 h and then selected in G418 (Gibco-BRL, Breda, The
Netherlands)-containing medium at concentrations of 1.5
(BAF3) or 0.8 (32D and L-GM) mg/ml. G418-resistant clones
were expanded and tested for their capacities to specifically
bind radiolabeled G-CSF. RT-PCR using primer sets FW2-
RV1 (5'GTAGATCTFTAGTCATGGGCTTATGG3'), FW2-
RV2, and FW2-RV3 (5'TCTCAGGGCACCGGCTTCTT
TT3') was performed on the transfectants to test for possible
incomplete transfer of sequences encoding the cytoplasmic
domains.
G-CSF binding assay. Recombinant human G-CSF (Am-
gen, Thousand Oaks, Calif.) was radioiodinated by the
method of Bolton and Hunter (2). G-CSF binding character-
istics were determined as previously described (4). In brief,
cells (106) were incubated with serial dilutions of radiola-
beled G-CSF ranging from 20 pM to 5 nM at 37°C for 1 h.
Incubations in the presence of excess nonlabeled G-CSF
were also performed to correct for nonspecific binding.
Bound ligand was separated from free ligand by centrifuga-
tion (5 min at 1,000 x g) through an ice-cold FCS layer.
Receptor numbers and binding affinity were calculated as
described previously (4).
DNA synthesis and cell proliferation assays. DNA synthesis
was assayed by [3H]thymidine ([3H]TdR) uptake. Cells (104)
were incubated in triplicate in 100-p,l of 10% FCS-RPMI
medium supplemented with titrated concentrations of
G-CSF or WEHI-CM (20%) in 96-well plates for 24 h.
Twelve hours before cell harvest, 1 ,uCi of [3H]TdR (2
Ci/mM; Amersham) was added to each well. [3H]TdR incor-
poration was measured by liquid scintillation counting as
described previously (40).
To quantify cell proliferation in suspension culture, cells
were incubated in 25-ml culture flasks at an initial density of
0.5 x 105/ml (5 ml of culture) in medium supplemented with
recombinant human G-CSF at the indicated concentrations
or without growth factors. Culture medium was refreshed
every 2 to 3 days, and the cell densities were adjusted to
approximately 0.5 x 105 to 1 x 105/ml. Viable cells were
counted on the basis of trypan blue exclusion.
Morphological examination. Cells were collected every 2
to 3 days and spun onto glass slides. Cell morphology was
examined after May-Grunwald-Giemsa staining.
RESULTS
Properties of the G-CSF-R variant and mutants. The struc-
tures of the different forms of the human G-CSF-R relevant
to this study are summarized in Fig. 1. DC represents an
RT-PCR product obtained from normal granulocytes that is
weakly expressed in comparison with the WT G-CSF-R
(data not shown). Nucleotide sequencing revealed that DC is
identical to the previously described splice variant D7,
derived from placenta (21). From amino acid 727, DC is
translated in an altered reading frame and contains 34
carboxy-terminal amino acids distinct from those of the WT
G-CSF-R. DA, derived from granulocytes of a patient with
congenital neutropenia, contains a C-to-T substitution at
nucleotide position 2384 that introduces a TAG stop codon
resulting in the truncation of 98 carboxy-terminal amino
acids. No other alterations were found in this mutant by
nucleotide sequencing. Ml contains only 55 amino acids in
the cytoplasmic domain that includes the two subdomains
called box 1 and box 2 (11, 29), with 3 additional amino acids
downstream. The different forms of the G-CSF-R were
introduced into the murine cell lines BAF3, 32D, and L-GM
by electroporation. RT-PCR products derived from the
transfectants by using primers that amplify the entire cyto-
plasmic domains all had the predicted sizes, indicating that
no deletions in these regions had occurred during transfec-
tion and clone selection (Fig. 2).
G-CSF binding to BAF3, 32D, and L-GM transfectants.
The numbers and dissociation constants of the G-CSF-R
expressed by the different transfected cell lines were estab-
lished following binding of 125I-radiolabeled G-CSF (Table
1). While the parental BAF3, 32D, and L-GM cells lacked
specific G-CSF binding (data not shown), the different BAF3
transfectants (WT, DC, DA, and Ml) expressed G-CSF
binding sites with affinities ranging from 0.28 to 2.04 nM
(Table 1), i.e., comparable to those of the G-CSF-R ex-
pressed on human peripheral blood neutrophils (4) and those
of the G-CSF-R expressed on cell line transfectants (13, 21,
49). 32D/WT, 32D/DC, 32D/DA, and L-GM/M1 transfec-
tants expressed G-CSF-R with similar average numbers and
affinities. On the other hand, 32D/M1, L-GMIWT, L-GM/
DC, and L-GM/DA transfectants expressed G-CSF-R at
detectable but lower densities (less than 100 sites per cell),
which did not allow estimation of binding affinities (Table 1).
The reasons for these variations in surface expression levels
of the G-CSF-R are unknown, but they may relate to
differences in protein stability or transportation in the differ-
ent cell line transfectants.
Mitogenic signaling by different forms of G-CSF-R. The
abilities of different forms of the G-CSF-R to transduce a
proliferative signal were first examined in [3H]TdR uptake
assays. At least three independent clones of each construct
were examined, giving comparable results. Parental BAF3,
32D, and L-GM cells or G418-resistant clones transfected
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FIG. 1. Schematic diagram of the G-CSF-R cDNAs. Boxes 1, 2, and 3 denote subdomains conserved in some members of the cytokine
receptor superfamily. The hatched box indicates the distinct cytoplasmic tail of the DC receptor from the corresponding region of the WT
receptor (see text). Lines indicate noncoding regions. The numbers in parentheses mark amino acid positions. TM, transmembrane domain.
with the vector without G-CSF-R showed no response to
G-CSF (Table 2). G-CSF induced DNA synthesis in BAF3
cells expressing the WT G-CSF-R to a level of approxi-
mately 40 to 50% of that induced by the optimal concentra-
tion of WEHI-CM (20%) as a source of murine IL-3 (Table 2
and Fig. 3A, BAF/WT). Deletion of 98 amino acids from the
carboxy terminus did not negatively affect G-CSF-induced
growth signaling in BAF3 cells (Table 2 and Fig. 3A,
BAF/DA). However, further deletion of 30 amino acids
significantly reduced the G-CSF sensitivity, resulting in a
100-fold increase in the G-CSF concentration (>100 ng/ml)
required to elicit a maximal response (Fig. 3A, BAF/Ml).
BAF3 cells expressing the DC receptor, which contains 11
additional amino acids as compared with the DA receptor,
followed by a distinct carboxy tail, also displayed a reduced
responsiveness: the magnitude of maximal response was
about 30 to 50% of that of BAF/WT cells (Table 2 and Fig.
3A, BAF/DC).
BAF 32D L-GM
kb M WT DC DA Ml WT DC DA Ml WT DC DA MI
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FIG. 2. RT-PCR analysis of the G-CSF-R cytoplasmic domain in
BAF3, 32D, and L-GM transfectants. Primer sets used for amplifi-
cation were FW2-RV1 for WT and DA, FW2-RV2 for DC, and
FW2-RV3 for Ml. For further details, see Materials and Methods.
Expected sizes of PCR products: 1,106 bp for WT and DA, 864 bp
for DC, and 630 bp for Ml.
In contrast to the BAF transfectants, 32D cells expressing
the WT G-CSF-R exhibited only a weak mitogenic response
to G-CSF (Table 2 and Fig. 3B, 32D/WT). Similar responses
to G-CSF were observed in 32D cells expressing the DC or
the Ml receptor (Table 2 and Fig. 3B). The 32D/DA cells,
however, showed a dramatic increase in responsiveness to
G-CSF (Fig. 3B, 32D/DA). Additional titration experiments
revealed that 32D/DA cells proliferated maximally at 0.1 ng
of G-CSF per ml (data not shown).
L-GM cells transfected with the different forms of the
G-CSF-R displayed a response pattern similar to that of 32D
transfectants (Table 2 and Fig. 3C). L-GM cells expressing
the WT G-CSF receptor showed a poor mitogenic response
to G-CSF, as did L-GM subclones expressing the DC or the
TABLE 1. Binding properties of the G-CSF receptors on cell
line transfectantsa
Cell type No. of Kd (nM)
BAF/WT 3,030 2.04
BAF/DC 1,500 0.67
BAF/DA 2,560 0.28
BAF/Ml 31,410 0.60
32D/WT 1,640 1.86
32D/DC 750 0.68
32D/DA 2,630 0.53
32D/M1 +b NDc
L-GM/WT + ND
L-GM/DC + ND
L-GM/DA + ND
L-GM/M1 1,290 1.84
a Parental BAF3, 32D, and L-GM celis did not show specific G-CSF
binding.
b +, specific binding detectable but too low for an accurate estimation of
receptor numbers and affinities.
c ND, not determined.
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TABLE 2. Mitogenic responses of cell line transfectants in
[3H]TdR uptake assay after 48 h of culture
dpm (mean + SD) with:
Transfectant IL-3 (20%No factor G-CSF (10 ng/ml) WEHI-CM)
BAF/Neo 33 6 52 20 46,298 +463
BAF/WT 35 + 14 17,845 + 393 36,833 + 1,289
BAF/DA 45 6 16,390 344 41,772+ 1,128
BAF/DC 20 ± 4 5,485 ± 527 19,673 ± 156
BAF/Ml 17 ± 5 7,190 ± 360 31,021 + 434
32D/Neo 33 + 13 29 ± 20 24,452 - 196
32D/WT 53 + 21 954 ± 134 19,780 ± 692
32D/DA 76 ± 47 22,606 ± 633 18,312 ± 549
32D/DC 38 ± 7 1,256 ± 72 14,765 - 221
32D/M1 149 ± 52 1,309 ± 94 27,554 + 1,350
L-GM/Neo 40 ± 13 39 ± 8 2,968 + 297
L-GM/WT 29 ± 7 383 ± 61 3,183 ± 267
L-GM/DA 43 ± 5 5,317 ± 393 3,293 - 59
L-GM/DC 22 ± 4 441 ± 46 1,566 + 49
L-GM/M1 22 ± 5 560 ± 50 1,369 + 178
Ml receptor. L-GM/DA cells, on the other hand, showed a
high rate of DNA synthesis even at low concentrations (0.1
ng/ml) of G-CSF.
Cell proliferation of transfectants. We next examined
whether G-CSF could replace IL-3 as a stimulus for sus-
tained proliferation of transfectants. As shown in Fig. 4A
and B, BAF/WT and BAF/DA cells became G-CSF depen-
dent and grew equally well in 1 and 100 ng of G-CSF per ml.
Although BAF/DC and BAF/Ml cells could also grow con-
tinuously at 100 ng of G-CSF per ml with a reduced rate of
proliferation (Fig. 4B), these cells could not survive at 1 ng
of G-CSF per ml (Fig. 4A). Cells proliferating exponentially
on G-CSF could be propagated for several months. The
response of BAF/Ml cells indicates that the membrane-
proximal region of 55 amino acids is sufficient for generating
a growth signal. In addition, the data show that a region
between amino acids 56 and 85 in the cytoplasmic domain
enhances growth signaling. The C-terminal region of the DC
receptor, which contains an additional 11 amino acids of the
WT receptor and 34 different amino acids in comparison with
0
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the DA mutant (Fig. 1), exerted a negative effect on growth
signaling in BAF3 cells.
The 32D transfectants expressing the WT, DC, and Ml
receptors died 4 days after transfer to G-CSF-containing
medium (Fig. 4C). In contrast, 32D/DA cells proliferated
continuously upon stimulation with G-CSF (Fig. 4C). Simi-
larly, L-GM/DA cells could be cultured continuously in
G-CSF-containing medium, whereas L-GM cells expressing
the WT, DC, or Ml receptor gradually lost viability (Fig.
4D). Thus, the characteristics of the responses observed in
32D and L-GM subclones define a functional subdomain
located in the distal carboxy-terminal region of the WT
G-CSF-R that appears to suppress the growth signaling in
myeloid cells. The altered carboxy terminus of the DC
receptor also inhibits G-CSF-induced proliferation of the
two myeloid cell lines.
Induction of myeloid maturation by different forms of
G-CSF-R. A prominent feature of G-CSF is its capacity to
induce neutrophilic differentiation. 32Dc13 and L-G cells,
variant cell lines of 32D and L-GM cells, respectively, have
previously been shown to mature into neutrophilic granulo-
cytes in response to G-CSF (22, 45). We therefore examined
whether L-GM and 32D cells expressing the different G-CSF
receptor structures would mature towards neutrophilic gran-
ulocytes following G-CSF induction. L-GM/WT cells exhib-
ited immature myeloblastic features when cultured in IL-3-
containing medium (Fig. 5a). Upon transfer to G-CSF-
containing medium, these cells gradually developed into
mature neutrophilic granulocytes, showing an enlarged cy-
toplasm-to-nucleus ratio and lobulated nuclei. On day 9 of
G-CSF induction, all cells displayed a morphology charac-
teristic of mature neutrophils (Fig. Sb), similar to that of
mature L-G cells (22). As shown in Fig. 5c and d, L-GM/DC
and L-GM/DA cells did not mature towards granulocytes in
G-CSF-containing medium. Identical results were obtained
with L-GMI/M1 transfectants (data not shown). Addition of
different concentrations of murine granulocyte macrophage-
CSF or murine IL-3 to the G-CSF-containing culture me-
dium to prolong cell survival also failed to induce terminal
maturation of L-GM/DC or L-GMI/M1 cells (data not
shown).
32D/WT cells, which were myeloblastic when cultured
with IL-3 (Fig. 5e), did not mature upon transfer to G-CSF-
containing medium. Instead, these cells manifested a pheno-
32D/WT
32D/DC
32D/DA
32D/Mi
32D
-- L-GM/WT
B 200 - L-GM/DC1 L-GM/DA
-1-0 L-GM/M1
4 C^ -i L-GM
.Q...ZT;0-
10 100 0o' ' 1 10 100 0o' ' 1 10 100
Recombinant human G-CSF (ng/ml)
FIG. 3. G-CSF responsiveness of BAF3, 32D, and L-GM cells expressing different forms of the G-CSF-R. Cell proliferation was measured
by the [3H]TdR uptake assay. Data represent the percentage of maximal response to IL-3 (20% WEHI-CM).
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FIG. 4. G-CSF-dependent long-term growth of BAF3, 32D, and L-GM transfectants. Cells maintained in IL-3-containing medium were
washed extensively and transferred to G-CSF-containing medium. Viable cell counts were determined at the indicated times. BAF3 subclones
were cultured in medium containing 1 (A) and 100 (B) ng of G-CSF per ml. 32D (C) and L-GM (D) transfectants were cultured in 10 ng of
G-CSF per ml, except for DA subclones (1 ng of G-CSF per ml).
type typical of apoptosis (i.e., condensation of nuclei) after
culture in G-CSF-containing medium for 4 days (Fig. Sf). To
exclude the possibility that these cells died from a lack of
growth signaling before they could undergo myeloid matu-
ration, cells were grown in G-CSF-containing medium sup-
plemented with different concentrations of WEHI-CM (1,
2.5, 5, and 10%) to allow survival for up to 2 weeks, but still
no maturation was noted (data not shown). Similarly,
32D/DC or 32D/M1 subclones were rapidly lost in cultures
supplemented with G-CSF and failed to mature (Fig. 5g and
data not shown). 32D/DA cells also showed no evidence of
terminal myeloid maturation when maintained in G-CSF
(Fig. 5h). These results show that the 32D cells used in this
study were incapable of granulocytic maturation in response
to G-CSF, suggesting a defect in the G-CSF-induced matu-
ration signaling pathway in these cells.
DISCUSSION
In this study, we have delineated distinct functional re-
gions in the cytoplasmic domain of the human G-CSF-R. We
show here that a membrane-proximal region of 55 amino
acids of the human G-CSF-R is sufficient to generate a
mitogenic signal, consistent with a recent report by Ziegler
et al. (48). This region contains two subdomains, termed box
1 and box 2, which are well conserved among some members
of the cytokine receptor superfamily (11, 29). The impor-
tance of the box 1- and box 2-containing region for growth
signal transduction has been demonstrated for several cyto-
kine receptors (7, 15, 26, 29, 35, 39, 48). It is likely that this
region is involved in activation of common or highly related
signal transduction pathways. This notion is supported by
several receptor transfection studies (7, 15, 29, 35, 48) and
by the fact that some of the ligands for these receptors
induce similar patterns of tyrosine phosphorylation (9, 27,
36).
The most prominent finding of this study is that the 98
carboxy-terminal amino acids of the WT G-CSF-R appeared
to be involved in neutrophilic maturation. Little is known of
the mechanisms by which hematopoietic growth factors
control maturation. For instance, it has remained a matter of
discussion whether activation of growth factor receptors
truly drives maturation or simply supports the proliferation
and survival of cells already programmed to mature along a
certain hematopoietic lineage (18, 28, 33). With regard to the
G-CSF-R, our results with the L-GM transfectants clearly
favor the first possibility, because L-GM/WT cells devel-
oped into morphologically mature granulocytes when cul-
tured in G-CSF, whereas L-GM/DA cells proliferated and
survived in G-CSF without any evidence of maturation. This
failure of L-GM/DA cells to mature was thus apparent in
spite of their ability to proliferate in response to G-CSF.
L-GM/DC and L-GM/M1 cells, which proliferated modestly
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FIG. 5. Morphological analysis of 32D and L-GM transfectants.
Shown are L-GM (a) and 32D (e) cells maintained in IL-3-containing
medium (10% WEHI-CM); L-GM/WT (b), L-GM/DC (c), and
L-GMIDA (d) cells cultured in medium containing 10 ng of G-CSF
per ml; and 32D/WT (f), 32D/DC (g), and 32/DA (h) cells in
G-CSF-containing medium. May-Grinwald-Giemsa staining was
used (original magnification, x63).
in response to G-CSF, were also incapable of maturation.
Our data therefore indicate that the carboxy-terminal part of
the WT G-CSF-R contains a subdomain critical for matura-
tion signaling that is required neither for proliferation nor for
survival. A linkage between the carboxy-terminal truncation
of the IL-2 gamma chain and T-cell maturation arrest in
patients with X-linked severe combined immunodeficiency
has recently been suggested (30). In G-CSF-R, a subdomain
designated box 3 has been identified in this region, which is
also present in the IL-6 signal transducer gpl30 (11). Nota-
bly, IL-6 also stimulates granulocytic colony formation by
normal mouse marrow cells (42) and was able to induce
maturation of Ml leukemia cells (17, 41). Moreover, leuke-
mia inhibitory factor and oncostatin M, which share gpl30
for signal transduction, have also been reported to induce
maturation of Ml cells (3). Thus, it appears likely that the
box 3 subdomain may have a direct role in the induction of
maturation, possibly through association with a specific
cytoplasmic substrate.
The presence of the carboxy-terminal region in the WT
G-CSF-R strongly inhibits the mitogenic signaling potential
of the G-CSF-R in two myeloid cell lines, 32D and L-GM
cells (Fig. 3). In contrast, this negative effect on growth
signaling was not evident in pro-B BAF3 cells, in which the
WT G-CSF-R transduces a growth signal as strong as that of
the DA mutant. Despite their enhanced sensitivity to
G-CSF, 32D/DA and L-GMI/DA cells remained fully factor
dependent and died within 48 h upon withdrawal of IL-3 or
G-CSF (data not shown).
In contrast to the L-GM transfectants, 32D cells express-
ing the WT G-CSF-R did not mature upon exposure to
G-CSF. However, the cells responded only transiently to
G-CSF in proliferation assays and could not be maintained in
G-CSF-containing suspension culture. These findings sug-
gest that the negative effect of the carboxy terminus of the
WT G-CSF-R on proliferation and the induction of terminal
maturation may be uncoupled and raise the possibility that
separate domains within this region are involved in these
functions. Alternatively, this could be explained by a lack of
downstream molecules involved in the maturation signaling
in the 32D cells.
It is still unclear by which mechanism proliferation signal-
ing in myeloid cells is inhibited by the carboxy-terminal
region of the WT G-CSF-R. Protein phosphorylation on
tyrosine or serine/threonine residues has been shown to be
frequently involved in the regulation of receptor function,
both positively and negatively (20, 43). One possibility is that
the down-regulation of the activity of the G-CSF-R is caused
by receptor phosphorylation, as has been demonstrated for
EPO-R (46). It is of note that, in contrast to our results with
BAF3/WT transfectants, the negative regulatory region of
the EPO-R also acted in BAF3 cells, suggesting that the
carboxy-terminal inhibitory regions of the G-CSF-R and
EPO-R act through different mechanisms. Alternatively, this
region may contain a subdomain that specifically activates
downstream molecules which transmit growth-inhibitory sig-
nals. In that case, these molecules would not be active in
BAF3 cells. A negative effect of the carboxy-terminal se-
quence on growth signal transduction has been reported for
several other growth factor receptors, including those of the
receptor tyrosine kinase family (7, 19, 37, 47). Thus, nega-
tive regulation of proliferation signaling by the carboxy-
terminal parts of receptors may be seen as a common feature
of different growth factor receptor systems.
We have further shown that a region of 30 amino acids
between residues 56 and 85 markedly augments the mito-
genic signaling potential of the G-CSF-R. A similar region
has been identified in the EPO-R and in the common chain
of IL-3, granulocyte macrophage-CSF, and IL-5 receptor
(31, 39). It remains to be established whether this region is
actively involved in transduction of a mitogenic signal or is
important simply for a proper conformation that facilitates
signaling from the box 1- and box 2-containing membrane-
proximal regions. In this respect, it is relevant that Ziegler et
al. have demonstrated that the region between amino acids
57 and 96 in the cytoplasmic domain of the G-CSF-R is
required for the induction of acute-phase protein gene ex-
pression by G-CSF in hepatoma cell line transfectants (48).
These data appear to suggest that this region indeed contains
a functional subdomain.
Whether the DC splice variant has a physiological role in
hematopoiesis is as yet unknown. We have shown that the
DC variant receptor is able to transduce a mitogenic signal in
the three murine cell lines, consistent with a previous report
(49). However, the growth signal transduced by the DC
receptor is significantly weaker than that transduced by the
DA mutant, suggesting that the alternative carboxy tail also
acts as a down-modulator of proliferation. Unlike the nega-
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tive regulatory region of the WT G-CSF-R, the DC tail
portion exerts its effect in both lymphoid and myeloid cells,
indicating that it must act by a mechanism different from that
of the WT G-CSF-R. Because the amino acid sequence in
this portion is rather hydrophobic (21), one possibility is that
the alternative tail folds towards the cell membrane, thereby
hindering the association of growth-signaling molecules with
other regions. Because the DC receptor is incompetent for
maturation induction, it might act as a negative regulator of
maturation at certain stages of myeloid development.
Our findings may have implications for studies dealing
with the granulocytic maturation defects in certain hemato-
logical diseases, such as neutropenias and acute myeloid
leukemia. The fact that G-CSF-R mutant DA was isolated
from a patient with severe congenital neutropenia strongly
suggests that defective G-CSF-R signaling had been involved
in the course of the disease, a possibility that is currently
being examined in detail.
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